Abstract
Objective
Methods
Results
Conclusion
Graphical abstract

Keywords
1. Introduction
Lung cancer statistics. London: World Cancer Research Fund International. Available from https://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/lungcancer-statistics [accessed 20 March 2020].
Dutch Institute for Clinical Auditing. Jaarrapportage Dutch Lung Cancer Audit 2018. Available from https://dica.nl/jaarrapportage-2018/dlca [accessed 14 September 2022].
Dutch Institute for Clinical Auditing. Jaarrapportage Dutch Lung Cancer Audit 2018. Available from https://dica.nl/jaarrapportage-2018/dlca [accessed 14 September 2022].
2. Methods
2.1 Literature search
2.2 Study selection
2.3 Data extraction
2.4 Methodological quality
2.5 Therapeutic quality
Low risk of ineffectiveness | High risk of ineffectiveness | |
---|---|---|
1. Patient selection | A VO2peak < 20 mL/kg/min and/or a predicted postoperative VO2peak < 10 mL/kg/min or other selection criteria with clear rationale. | No preselection or selection (described). |
2. Dosage of the training program | Intensity and duration of the exercise program must be clearly described and/or based on existing literature relevant to the target population of operable patients with NSCLC and/or an adequate exercise test (e.g., steep ramp test, CPET). | Not described where (the intensity of) the content of the exercise is based on and/or no physiological improvement can be expected due to low training dosage (frequency, intensity, time). |
3. Type of the training program | At least aerobic exercise training with or without resistance exercise training. | An intervention inconsistent with the goal of physical exercise training for patients undergoing surgery for lung cancer. |
4. Qualified supervisor (if applicable) | Guidance of a physical therapist who is specialized in supervising adult clinical populations. | Supervision is not reported or guidance was provided by a professional other than a physical therapist, or guidance is not described. |
5. Type and timing of outcome assessment |
| Less than 30 days or more than 90 days postoperatively description of follow-up. |
6. Safety of the training program | Adverse events related to the exercise program are described and acceptable as would be expected in the studied population. | Adverse events related to the exercise program are higher than would be expected in the studied population. |
7. Adherence to the training program | Adherence was determined separately for training frequency and deemed good in case of ≥80%. | Adherence to the training frequency was <80%. |
2.6 Data synthesis
2.7 Certainty of evidence
3. Results
3.1 Study characteristics
First author, year |
|
| Age, year, ±SD (range) | Comorbidity, n (%) | Type of surgery, n | Postoperative outcomes |
---|---|---|---|---|---|---|
Benzo, [ [25] ] 2011 |
|
| Prehab: 70.2 ± 8.6, UC: 72.0 ± 6.7, p = 0.71 |
|
|
|
Boujibar, [ [26] ] 2018 |
|
| Prehab: 69 (56–73), UC: 65 (59–71), p = 0.61 |
|
|
|
Huang, [ [37] ] 2017 |
|
| Prehab: 63.0 ± 8.7 UC: 63.6 ± 6.5 p = 0.75 |
|
|
|
Lai, [ [27] ] 2016 |
|
| Prehab: 72.5, ±3.4, UC: 71.6, ±1.9, p = 0.23 |
|
|
|
Lai, [ [27] ] 2017 |
|
III: Prehab: 6, UC: 5 IV: Prehab: 1, UC: 0
| Prehab: 63.8 ± 8.2, UC: 64.6 ± 6.6, p = 0.58 |
|
|
|
Lai, [ [29] ] 2019 |
|
| Prehab: 64.2 ± 6.8, UC: 63.4 ± 8.2, p = 0.67 |
|
|
|
Licker, [ [30] ] 2017 |
|
III: Prehab: 13, UC: 10
| Prehab: 64 ± 10 UC: 64 ± 13, p = 0.74 |
|
|
|
Liu, [ [31] ] 2019 |
|
| Prehab: 56.2 ± 10.3, UC: 56.2 ± 8.7, p = NR |
|
|
|
Morano, [ [34] ] 2013 |
|
| Prehab: 64.8 ± 8, UC: 68.8 ± 7.3, p = 0.33 |
|
|
|
Pehlivan, [ [35] ] 2011 |
|
| Prehab 54.1 ± 8.5 UC 54.8 ± 8.5, p = 0.70 |
|
|
|
Rispoli, [ [40] ] 2020 |
|
| Prehab 1: 69.3 ± 1.4, Prehab2: 69.7 ± 3.5, p = 0.74 |
|
|
|
Saito, [ [39] ] 2017 |
|
| Prehab: 74.4 ± 7.7, UC: 68.2 ± 8.6, p < 0.01 |
|
|
|
Saito, [ [38] ] 2021 |
|
| Prehab: 73.0 ± 6.0 UC: 71.3 ± 7.3, p = 0.15 |
|
|
|
Sebio Garcia, [ [33] ] 2016 |
|
| Prehab: 70.9 ± 6.1 UC: 69.0 ± 4.4, p = NR |
|
|
|
Tenconi, [ [36] ] 2021 |
|
| Prehab: 66.0 ± 10.6 UC: 67.7 ± 10.8, p = NR |
|
|
|
Zhou [ [32] ] 2017 |
|
| Prehab: 58.5 ± 9.6, UC: 58.8 ± 9.3, p = 0.56 |
|
|
|
3.2 Exercise prehabilitation characteristics
First author, year | Patient selection Eligible if: | Type and dosage of the preoperative exercise program (F: Frequency, I: intensity, T: Time, T: Type) | Qualified supervisor | Type and timing of outcome assessment | Safety dropouts and adherence, n (%) (range) |
---|---|---|---|---|---|
Benzo, [ [25] ] 2011 | Low-risk group: Moderate to severe COPD and FEV1 <80% |
Resistance exercises: F: 2/day, I: at least light intensity on the Borg scale, T: 2 × 10–12 repetitions, T: Thera band Breathing exercises: F: 1/day, I: perceived exertion of somewhat hard on the Borg scale, T: 15–20 repetitions, T: Threshold Inspiratory Muscle Trainer or P-Flex valve | Physical therapist |
| |
Boujibar, [ [26] ] 2018 | High-risk group: ≥18 years and VO2peak ≤ 20 mL/kg/min |
Resistance exercises: F: 3–5/week, I: 70% of 1RM, T: 3 × 12 repetitions, T: NR, Breathing exercises: F: 3–5/week, I: 30% of maximum inspiratory pressure, T: NR, T: Threshold Inspiratory Muscle Trainer | Physical therapists |
|
|
Huang, [ [37] ] 2017 | High-risk group: Age >70 years, BMI >30, COPD with heavy smoking history (≥20 pack-years) FEV1 ≤70%, or prior thoracic surgery |
Breathing exercises: F: 2–3/day, I: NR, T: 15–20, T: Threshold Inspiratory Muscle Trainer | Aerobic exercises in hospital with a physical therapist, breathing exercises with trained nurses. |
|
|
Lai, [ [27] ] 2016 | Low-risk group: ≥70 years |
| Aerobic exercises supervised by a physical therapist |
|
|
Lai, [ [28] ] 2017 | High-risk group: >75 years and >20 pack-year smoking history and BMI >30 kg/m2 and ppoFEV1 <60% and ppoDLCO <60% and COPD |
Breathing exercises: F: 2–3/day, I: NR, T: 15–20 min, T: Threshold Inspiratory Muscle Trainer and manual deep breathing exercises | Physical therapist dedicated to thoracic surgery patients |
|
|
Lai, [ [29] ] 2019 | Low-risk group: 45–80 years and ppoFEV1 <60%, |
Breathing exercises: F: 3/day, I: NR, T: 20 breaths/session, T: Threshold Inspiratory Muscle Trainer | Aerobic exercises supervised by a physical therapist, respiratory exercises supervised by a trained nurse |
|
|
Licker, [ [30] ] 2017 | Low-risk group: All patients |
Resistance training: F: 2–3/week, I: NR, T: NR, T: leg press, leg extension, back extension, seat row, biceps curls, or chest and shoulder press | Physical therapist specialized in rehabilitation |
|
|
Liu, [ [31] ] 2019 | Low-risk group: <70 years |
Resistance exercises: F: 2/week, I: Borg-score moderate to high (13–16), T: 3 x 3–12 repetitions, T: major muscle groups with Thera band Breathing exercises: F: 2/day, I: NR, T: 10 min, T: 1) A Tri-Ball Respiratory Training (Leventon S.A., Barcelona, Spain) for breathing exercises; 2) cough exercises; 3) blowing up a small balloon in 1 breath and holding for >5 s | Home-based, instruction and resistance exercises supported by a physical therapist |
|
|
Morano, [ [34] ] 2013 | High-risk group: Previous pulmonary disease, interstitial lung disease, COPD with impaired spirometry function |
Breathing exercises: F: 1/day, I: 20% on the maximal inspiratory pressure (MIP), increased 5–10% each session, to reach 60% of their MIP, T: 10–30 min, T: Threshold Inspiratory Muscle Trainer | NR |
|
|
Pehlivan, [ [35] ] 2011 | Low-risk group: ASA I-II |
| Physical therapist |
|
|
Rispoli, [ [40] ] 2020 | Low-risk group: COPD stage I | F: ≥3/week, I: at least 15 min or dyspnoea-limited, T: 30 min, T: walking outside or treadmill Resistance exercises: F: ≥3/week, I: NR, T: NR, T: abdominal exercises, lower limbs exercises Breathing exercises: F: NR, I: NR, T: NR, T: incentive spirometry | Home-based instruction and weekly phone calls supported by a physical therapist |
|
|
Saito, [ [39] ] 2017 | Low-risk group: COPD gold ≥ II and FEV1 <100% and ECOG ≥2 |
Resistance exercises: F: 5/week, I: NR, T: NR, T: bronchodilator, training for chest expansion, shoulder girdle mobilization | Aerobic exercises supervised by a physical therapist |
|
|
Saito, [ [38] ] 2021 | Low-risk group: All patients |
Breathing exercises: F: 7/week, I: NR, T: based on vital capacity 50–100 breaths/session, T: incentive spirometry coach2 | Physical therapist at the first instance of home-based exercises |
|
|
Sebio Garcia [ [33] ], 2016 | High-risk group: FEV1 ⩽80%, BMI ⩾30; (c) age ⩾75 years or two or more co-morbidities identified in the Colinet Comorbidity Score. |
Resistance exercises: F: 3–5/week, I: 25 repetition maximum test, T: 3 × 15 repetitions, T: six training using Thera band and body mass for the large muscle groups Breathing exercises: F: 2/day, I: 80% of vital capacity, T: 6 cycles of 5 repetitions, T: incentive spirometry coach2 | Physical therapist |
|
|
Tenconi, [ [36] ] 2021 | Low-risk group: All patients |
Resistance exercises: F: 2–3/week, I: maximal load (previously determined with the 10-repetition maximum test), T: 2–3x 10 repetitions, T: lower limbs (extensor muscle group), upper limbs (biceps, triceps, deltoids, latissimus dorsi, pectoralis) and abdominal wall Breathing exercises: F: 1/day, I: ≥30% of maximal predicted inspiratory pressure and adapted to the patient's tolerance, T: 15–30 min, T: Threshold Inspiratory Muscle Trainer | Physical therapist |
|
|
Zhou, [ [32] ] 2017 | High-risk group: ≥50 years and ≥20 pack-year smoking history and BMI ≥28 kg/m2 and FEV1 ≤60% and COPD, asthma or airway hyper reactivity |
Breathing exercises: F: 2–3/day: I: NR, T: 15–20 min, T: Volume training: abdominal breathing and inspiratory training with the Voldyne 2500 | Education and teaching supported by a nursed specialized in lung cancer, aerobic exercise supervised by a physical therapist |
|
|
3.3 Methodological quality of the studies

3.4 Therapeutic quality of the exercise prehabilitation programs
3.5 Effects of prehabilitation on postoperative complications, length of hospital stay, and postoperative mortality
3.5.1 Postoperative pulmonary complications


Certainty assessment | Number of patients | Effect | Certainty | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | 1. Publications bias 2. Residual confounding 3. Dose-response gradient 4. Risk of ineffectiveness | Exercise prehabilitation with event/total | Usual care with event/total | Relative (95% CI) | absolute (95% CI) | |
Postoperative pulmonary complications (follow up: 90 days) | |||||||||||
8 | Randomized controlled trials | Serious, | Not serious | Not serious | Not serious |
| 41/248 (16.5%) | 95/251 (37.8%) | OR 0.31 (0.20–0.48) | 220 fewer per 1.000 (from 270 less to 152 less) | ⨁⨁⨁◯ Moderate |
Postoperative pulmonary complications (follow up: 90 days) | |||||||||||
2 | Observational studies | Very serious, | Not serious | Not serious | Not serious |
| 39/248 (15.7%) | 204/807 (25.3%) | OR 0.60 (0.41–0.88) | 84 fewer per 1.000 (from 131 less to 23 less) | ⨁◯◯◯ Very low |
Postoperative any complications (follow up: 90 days) | |||||||||||
11 | Randomized controlled trials | Very serious, | Not serious | Not serious | Not serious |
| 112/387 (28.9%) | 116/300 (38.7%) | OR 0.37 (0.23–0.61) | 198 fewer per 1.000 (from 260 less to 109 less) | ⨁⨁◯◯ Low |
Postoperative any complications (follow up: 90 days) | |||||||||||
4 | Observational studies | Very serious, | Not serious | Not serious | Serious |
| 116/300 (38.7%) | 468/915 (51.1%) | OR 0.58 (0.35–0.97) | 134 fewer per 1.000 (from 243 less to 8 less) | ⨁◯◯◯ Very low |
Postoperative severe complications (follow up: 90 days) | |||||||||||
4 | Randomized controlled trials | Very serious, | Not serious | Not serious | Not serious |
| 19/131 (14.5%) | 41/130 (31.5%) | OR 0.36 (0.20–0.68) | 173 fewer per 1.000 (from 231 less to 77 less) | ⨁⨁⨁◯ Moderate |
Postoperative severe complications (follow up: 90 days) | |||||||||||
3 | Observational studies | Very serious, | Not serious | Not serious | Not serious |
| 96/267 (36.0%) | 422/850 (49.6%) | OR 0.56 (0.29–1.06) | 141 fewer per 1.000 (from 274 less to 15 less) | ⨁⨁◯◯ Low |
Postoperative mortality (follow up: 90 days) | |||||||||||
6 | Randomized controlled trials | Very serious, | Not serious | Not serious | extremely serious |
| 2/235 (0.9%) | 4/235 (1.7%) | OR 0.63 (0.14–2.83) | 28 fewer per 1.000 (from 15 less to 30 more) | ⨁◯◯◯ Very low |
Postoperative mortality (follow up: 90 days) | |||||||||||
2 | Observational studies | Very serious, | Not serious | Not serious | extremely seriousf |
| 3/248 (1.2%) | 5/835 (0.6%) | OR 1.11 (0.39–3.14) | 1 more per 1.000 (from 4 less to 13 more) | ⨁◯◯◯ Very low |
Length of hospital stay | |||||||||||
15 | Randomized controlled trials | Very serious, | Serious | Not serious | Not serious |
| 232 | 230 | – | MD 3.02 lower (4.82 less to 1.22 less) | ⨁◯◯◯ Very low |
Length of hospital stay | |||||||||||
3 | Observational studies | Very serious, | Serious | Not serious | Serious, |
| 299 | 900 | – | MD 0.6 lower (3.95 lower to 2.75 higher) | ⨁◯◯◯ Very low |
3.5.2 Any postoperative complications
3.5.3 Severe postoperative complications
3.5.4 Postoperative mortality
3.5.5 Length of hospital stay
4. Discussion
- Morano M.T.
- Araujo A.S.
- Nascimento F.B.
- et al.